Response to physical rehabilitation and recovery trajectories following critical illness: individual participant data meta-analysis protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
04 05 2020
Historique:
entrez: 7 5 2020
pubmed: 7 5 2020
medline: 18 2 2021
Statut: epublish

Résumé

The number of inconclusive physical rehabilitation randomised controlled trials for patients with critical illness is increasing. Evidence suggests critical illness patient subgroups may exist that benefit from targeted physical rehabilitation interventions that could improve their recovery trajectory. We aim to identify critical illness patient subgroups that respond to physical rehabilitation and map recovery trajectories according to physical function and quality of life outcomes. Additionally, the utilisation of healthcare resources will be examined for subgroups identified. This is an individual participant data meta-analysis protocol. A systematic literature review was conducted for randomised controlled trials that delivered additional physical rehabilitation for patients with critical illness during their acute hospital stay, assessed chronic disease burden, with a minimum follow-up period of 3 months measuring performance-based physical function and health-related quality of life outcomes. From 2178 records retrieved in the systematic literature review, four eligible trials were identified by two independent reviewers. Principal investigators of eligible trials were invited to contribute their data to this individual participant data meta-analysis. Risk of bias will be assessed (Cochrane risk of bias tool for randomised trials). Participant and trial characteristics, interventions and outcomes data of included studies will be summarised. Meta-analyses will entail a one-stage model, which will account for the heterogeneity across and the clustering between studies. Multiple imputation using chained equations will be used to account for the missing data. This individual participant data meta-analysis does not require ethical review as anonymised participant data will be used and no new data collected. Additionally, eligible trials were granted approval by institutional review boards or research ethics committees and informed consent was provided for participants. Data sharing agreements are in place permitting contribution of data. The study findings will be disseminated at conferences and through peer-reviewed publications. CRD42019152526.

Identifiants

pubmed: 32371516
pii: bmjopen-2019-035613
doi: 10.1136/bmjopen-2019-035613
pmc: PMC7223158
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e035613

Subventions

Organisme : Chief Scientist Office
ID : CZH/4/531
Pays : United Kingdom
Organisme : NINR NIH HHS
ID : R01 NR011051
Pays : United States
Organisme : Chief Scientist Office [UK]
ID : CZH/4/531
Pays : International
Organisme : NHLBI NIH HHS
ID : K24 HL089223
Pays : United States

Investigateurs

Sue Berney (S)
Michael J Berry (MJ)
Linda Denehy (L)
D Clark Files (D)
David M Griffith (DM)
Jennifer R A Jones (JRA)
Peter E Morris (PE)
Marc Moss (M)
Amy Nordon-Craft (A)
Zudin Puthucheary (Z)
Timothy Walsh (T)

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Ann Am Thorac Soc. 2019 Apr;16(4):471-477
pubmed: 30571923
Stat Med. 2015 May 20;34(11):1841-63
pubmed: 25663182
J Clin Epidemiol. 2004 Mar;57(3):229-36
pubmed: 15066682
JAMA. 2016 Jun 28;315(24):2694-702
pubmed: 27367766
N Engl J Med. 2011 Apr 7;364(14):1293-304
pubmed: 21470008
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Intensive Care Med. 2016 Oct;42(10):1557-1566
pubmed: 27637716
PLoS One. 2015 Jul 01;10(7):e0130722
pubmed: 26132803
Crit Care. 2010;14(2):R67
pubmed: 20398310
Crit Care Med. 2014 Apr;42(4):849-59
pubmed: 24247473
Crit Care Med. 2018 Apr;46(4):594-601
pubmed: 29293149
Arch Gen Psychiatry. 2002 Oct;59(10):877-83
pubmed: 12365874
Intensive Care Med. 2005 May;31(5):611-20
pubmed: 15803303
Am J Respir Crit Care Med. 2013 Sep 1;188(5):567-76
pubmed: 23805899
J Clin Epidemiol. 2013 Aug;66(8):865-873.e4
pubmed: 23651765
Crit Care Med. 2016 Jun;44(6):e362-9
pubmed: 26974547
Am J Respir Crit Care Med. 2016 May 15;193(10):1101-10
pubmed: 26651376
Crit Care Med. 2013 Jun;41(6):1543-54
pubmed: 23528802
J Clin Epidemiol. 2005 Jun;58(6):595-602
pubmed: 15878473
Am J Respir Crit Care Med. 2017 Nov 1;196(9):1122-1130
pubmed: 28537429
PLoS One. 2012;7(10):e46042
pubmed: 23056232
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Crit Care. 2013 Jul 24;17(4):R156
pubmed: 23883525
BMJ Open. 2018 May 5;8(5):e019998
pubmed: 29730622
Thorax. 2018 Mar;73(3):213-221
pubmed: 28780504
Intensive Care Med. 2017 Feb;43(2):171-183
pubmed: 27864615
Res Synth Methods. 2015 Dec;6(4):293-309
pubmed: 26287812
JAMA. 2015 Apr 28;313(16):1657-65
pubmed: 25919529
Clin Epidemiol. 2015 Jan 16;7:91-106
pubmed: 25653557
JAMA Intern Med. 2015 Jun;175(6):901-10
pubmed: 25867659
BMJ. 2018 Jan 3;360:j5748
pubmed: 29298779
Ann Am Thorac Soc. 2017 May;14(5):766-777
pubmed: 28231030
Crit Care. 2017 Jul 21;21(1):190
pubmed: 28732512
Am J Respir Crit Care Med. 2016 Oct 1;194(7):831-844
pubmed: 26974173
Clin Epidemiol. 2017 Jun 08;9:331-338
pubmed: 28652815
BMJ. 2010 Feb 05;340:c221
pubmed: 20139215
Am J Respir Crit Care Med. 2015 Jun 15;191(12):1464-7
pubmed: 26075426
Stat Med. 2018 Dec 20;37(29):4404-4420
pubmed: 30101507
BMJ. 2011 Jul 22;343:d4002
pubmed: 21784880

Auteurs

Jennifer R A Jones (JRA)

Physiotherapy Department, The University of Melbourne, Parkville, Victoria, Australia jrjones@student.unimelb.edu.au.
Physiotherapy Department, Division of Allied Health, Austin Health, Heidelberg, Victoria, Australia.

Sue Berney (S)

Physiotherapy Department, The University of Melbourne, Parkville, Victoria, Australia.
Physiotherapy Department, Division of Allied Health, Austin Health, Heidelberg, Victoria, Australia.

Michael J Berry (MJ)

Department of Health and Exercise Science, Wake Forest University, Winston-Salem, North Carolina, USA.

D Clark Files (DC)

Pulmonary, Critical Care, Allergy and Immunologic Disease, Wake Forest University, Winston-Salem, North Carolina, USA.
Wake Forest Critical Illness Injury and Recovery Research Center, Wake Forest University, Winston-Salem, North Carolina, USA.

David M Griffith (DM)

Anaesthesia, Critical Care and Pain, University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, UK.

Luke A McDonald (LA)

Physiotherapy Department, Division of Allied Health, Austin Health, Heidelberg, Victoria, Australia.

Peter E Morris (PE)

Division of Pulmonary, Critical Care and Sleep Medicine, University of Kentucky, Lexington, Kentucky, USA.

Marc Moss (M)

Division of Pulmonary Sciences & Critical Care Medicine, University of Colorado Denver School of Medicine, Aurora, Colorado, USA.

Amy Nordon-Craft (A)

Physical Therapy Program, University of Colorado Denver School of Medicine, Aurora, Colorado, USA.

Timothy Walsh (T)

Anaesthesia, Critical Care and Pain, University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, UK.

Ian Gordon (I)

Statistical Consulting Centre, The University of Melbourne, Parkville, Victoria, Australia.

Amalia Karahalios (A)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.

Zudin Puthucheary (Z)

William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London, UK.

Linda Denehy (L)

Melbourne School of Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.
Allied Health, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH